<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04208139</url>
  </required_header>
  <id_info>
    <org_study_id>Version 1.0</org_study_id>
    <nct_id>NCT04208139</nct_id>
  </id_info>
  <brief_title>A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center Follow up</brief_title>
  <official_title>A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NC Heart and Vascular Research, LLC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Novate Medical Limited, a BTG Group Company</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>NC Heart and Vascular Research, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      IVUS Evaluation of the Bioabsorbable Sentry IVC Filter 3-5 Years Post Deployment Follow up
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      IVUS Evaluation of the Bioabsorbable Sentry IVC Filter 3-5 Years Post Deployment Follow up
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 30, 2020</start_date>
  <completion_date type="Anticipated">May 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patency of the inferior vena cava</measure>
    <time_frame>3-5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cylindrical frame integrity</measure>
    <time_frame>3-5 years</time_frame>
    <description>Cylindrical frame integrity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact of the Sentry cylindrical frame on the vessel wall evaluation for endothelialization and neointimal hyperplasia and wall dynamics</measure>
    <time_frame>3-5 years</time_frame>
    <description>Impact of the Sentry cylindrical frame on the vessel wall evaluation for endothelialization and neointimal hyperplasia and wall dynamics</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Presence and characterization of adherent thrombus</measure>
    <time_frame>3-5 years</time_frame>
    <description>Presence and characterization of adherent thrombus</description>
  </primary_outcome>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Recurrent Pulmonary Embolism (Disorder)</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>IVUS</intervention_name>
    <description>IVUS</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with at least 24 months dwell time will undergo IVUS assessment of the inferior
        vena cava
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age

          -  Signed the informed consent document

          -  Participants from the SENTRY clinical trial willing to undergo one time IVUS
             evaluation ( outpatient )

        Exclusion Criteria:

          -  Any filter that remained non converted.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Robert Mendes, MD</last_name>
    <phone>919-784-2300</phone>
    <email>robert.mendes@unchealth.unc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rebecca Palermo, MS</last_name>
    <phone>919-784-3795</phone>
    <email>rebecca.palermo@unchealth.unc.edu</email>
  </overall_contact_backup>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 3, 2019</study_first_submitted>
  <study_first_submitted_qc>December 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2019</study_first_posted>
  <last_update_submitted>February 24, 2020</last_update_submitted>
  <last_update_submitted_qc>February 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

